92 related articles for article (PubMed ID: 2188335)
41. Controlled evaluation of allergoid in the immunotherapy of ragweed hay fever.
Norman PS; Lichtenstein LM; Kagey-Sobotka A; Marsh DG
J Allergy Clin Immunol; 1982 Oct; 70(4):248-60. PubMed ID: 6181113
[TBL] [Abstract][Full Text] [Related]
42. Semi-depot hyposensitization in severe hay fever: its clinical effectiveness and the therapeutic problems. (A four year study using intranasal challenge testing to monitor success).
Rudolph R; Staud RT; Kunkel G; Baumgarten C
Allergol Immunopathol (Madr); 1978; 6(2):133-52. PubMed ID: 747146
[TBL] [Abstract][Full Text] [Related]
43. Hyposensitization of patients with allergic rhinitis by intranasal administration of chemically modified grass pollen allergen. A pilot study.
Deuschl H; Johansson GO
Acta Allergol; 1977 Aug; 32(4):248-62. PubMed ID: 578362
[TBL] [Abstract][Full Text] [Related]
44. Safety and tolerability of immunotherapy using various updosing schedules of a new SCIT product with an optimised allergen/aluminium hydroxide ratio.
Jung K
Allergy; 2011 Jul; 66 Suppl 95():41-3. PubMed ID: 21668852
[TBL] [Abstract][Full Text] [Related]
45. Preseasonal specific immunotherapy with modified phleum pratense allergenic extracts: tolerability and effects.
Vittorio R; Giorgio C; Giampaola G; Annamaria R; Paola V; Silvia P; Walter CG
Allergol Immunopathol (Madr); 1996; 24(6):255-62. PubMed ID: 9010561
[TBL] [Abstract][Full Text] [Related]
46. [Peroral specific hyposensitization in ambrosia-induced pollinosis].
Mikhaĭlov EL
Sov Med; 1976; (5):110-3. PubMed ID: 968591
[No Abstract] [Full Text] [Related]
47. [Evaluation of effectiveness and safety of three year immunotherapy with mixed grass pollen allergens].
Gietkiewicz K; Fal AM; Małolepszy J
Pol Arch Med Wewn; 2001 Dec; 106(6):1163-8. PubMed ID: 12026536
[TBL] [Abstract][Full Text] [Related]
48. Double-blind, placebo-controlled immunotherapy with a high-molecular-weight, formalinized allergoid in grass pollen allergy.
Bousquet J; Frank E; Soussana M; Hejjaoui A; Maasch HJ; Michel FB
Int Arch Allergy Appl Immunol; 1987; 82(3-4):550-2. PubMed ID: 3553031
[TBL] [Abstract][Full Text] [Related]
49. Side effects during immunotherapy with purified grass pollen extracts.
Osterballe O
Allergy; 1982 Nov; 37(8):553-62. PubMed ID: 7181051
[TBL] [Abstract][Full Text] [Related]
50. Treatment of hay fever with sodium cromoglycate, hyposensitization, or a combination.
Andersen NH; Jeppesen F; Schiøler T; Osterballe O
Allergy; 1987 Jul; 42(5):343-51. PubMed ID: 3115130
[TBL] [Abstract][Full Text] [Related]
51. [Desensitization for 4 successive years using calcium phosphate-adsorbed pollen extracts: study of sera with RAST and PRIST immunoimprints].
Donat N; Thibaudon M; Peltre G; David B
Allerg Immunol (Paris); 1986 Sep; 18(7):24-31. PubMed ID: 3331108
[TBL] [Abstract][Full Text] [Related]
52. Further evaluation of local intranasal immunotherapy with aqueous and allergoid grass extracts.
Georgitis JW; Clayton WF; Wypych JI; Barde SH; Reisman RE
J Allergy Clin Immunol; 1984 Nov; 74(5):694-700. PubMed ID: 6389648
[TBL] [Abstract][Full Text] [Related]
53. Immunohistochemical investigation of the cellular infiltrates at the sites of allergoid-induced late-phase cutaneous reactions associated with pollen allergen-specific immunotherapy.
Eberlein-König B; Jung C; Rakoski J; Ring J
Clin Exp Allergy; 1999 Dec; 29(12):1641-7. PubMed ID: 10594540
[TBL] [Abstract][Full Text] [Related]
54. [Immunological and clinical studies on the pollen-L-tyrosin complexes in hyposensitization therapy].
Horak F
Wien Med Wochenschr; 1977 Nov; 127(22):677-81. PubMed ID: 595610
[No Abstract] [Full Text] [Related]
55. Local intranasal immunotherapy for grass-allergic rhinitis.
Georgitis JW; Reisman RE; Clayton WF; Mueller UR; Wypych JI; Arbesman CE
J Allergy Clin Immunol; 1983 Jan; 71(1 Pt 1):71-6. PubMed ID: 6337198
[TBL] [Abstract][Full Text] [Related]
56. Grass pollen allergoid. A 4-year follow-up study.
Baumgarten C; Kunkel G; Rudolph R
Respiration; 1984; 46(1):97-104. PubMed ID: 6494611
[TBL] [Abstract][Full Text] [Related]
57. Influence of preseasonal treatment with L-tyrosine-adsorbed allergoids on IgE-mediated histamine release from basophils of children suffering from allergic diseases.
Wegner F; Fenkes A; Stemmann EA; Reinhardt D
Agents Actions; 1981 Apr; 11(1-2):111-3. PubMed ID: 6166163
[TBL] [Abstract][Full Text] [Related]
58. [Allergens adsorbed on aluminum hydroxide preparation, standardization controls and therapeutic results].
Relyveld EH; Henocq E
Dev Biol Stand; 1975; 29():295-307. PubMed ID: 1149938
[TBL] [Abstract][Full Text] [Related]
59. Grass pollen hyposensitization versus placebo therapy. I. Clinical effectiveness and methodological aspects of a pre-seasonal course of desensitization with a four-grass pollen extract.
Weyer A; Donat N; L'Heritier C; Juilliard F; Pauli G; Soufflet B; David B
Allergy; 1981 Jul; 36(5):309-17. PubMed ID: 7032341
[TBL] [Abstract][Full Text] [Related]
60. Treatment of hay fever in general practice by hyposensitization, using 'Pollinex'.
Purser JR
Curr Med Res Opin; 1976; 4(2):124-7. PubMed ID: 1277879
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
